Swiss government recommends Covid booster from mid-October
Around 69% of the Swiss population have so far received two doses of vaccine.
Keystone / Gian Ehrenzeller
The Swiss authorities have recommended that people aged over 16, especially the most vulnerable, get a Covid-19 booster shot to contain a new wave of infections expected this autumn and winter.
This content was published on
3 minutes
SRF/FOPH/swissinfo.ch/sb
Português
pt
Governo suíço recomenda reforço de vacina a partir de meados de outubro
After a rise in new Covid infections in June and July due to new Omicron subvariants, cases have fallen and stabilised at a “relatively low level” in Switzerland, the Federal Office of Public Health (FOPH) saidExternal link on Friday. The number of hospital admissions is also down.
“However, based on experiences so far with SARS-CoV-2, an increase in transmissions of the virus is expected from the fall [autumn] of 2022. The risk of contracting COVID-19 and the burden for the health system could therefore increase again,” it said.
The Swiss authorities therefore recommend as a priority that people aged 65 or over, and those aged 16 to 64 with an increased risk, for example anyone with a pre-existing disease or pregnant women, get a Covid booster shot this autumn. This recommendation also applies to healthcare workers.
For anyone aged 16-64 without risk factors, a booster vaccination “makes sense after individual assessment… to reduce the risk of a serious and rare infection”, FOPH said.
Young people, aged 5-15, do not need a booster jab, as Covid symptoms are generally light or non-existent, according to the authorities. Young people who have already been infected have sufficient antibodies 16 months after getting the virus. No vaccine authorisation has been issued in Switzerland for the under-fives.
The authorities recommend both mRNA Covid vaccines, such as those from Pfizer/BioNTech or Moderna, and the protein-based Nuvaxovid vaccine as boosters. New so-called bivalent mRNA vaccines, which are tailored to the BA.1 version of Omicron and the original virus first detected in China, should be preferred for booster vaccination. But it is still possible to use the current monovalent mRNA vaccine, FOPH said.
Switzerland will receive three and a half million doses of the bivalent vaccine Spikevax from Moderna by the end of September.
Covid certificates will continue to be issued to prove vaccinations, attest to infection or show negative test results. Currently, the certificate is not used in Switzerland, but may be requested by certain countries.
The booster should be given at least four months after the last vaccination or recovery. All vaccinations that meet FOPH recommendations are free of charge. The new vaccination recommendations will come into effect on October 10, 2022.
New coronavirus infections and hospital admissions continue to fall in Switzerland. A total of 14,475 new Covid cases were reported on September 6 for the previous seven-day period, down 5.4% on the previous week. There were 196 new hospital admissions and seven reported deaths.
Around 69% of the population have so far received two doses of vaccine.
Looking ahead, the FOPH said the situation “differs markedly from that of the last two winters”. Currently, 97% of the population have antibodies against SARS-CoV-2 following vaccination or recovery.
“People without risk factors are unlikely to develop severe symptoms this fall,” it said.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Swiss parliamentary commission to investigate F-35 purchase
This content was published on
The Swiss government and the other responsible authorities must once again answer critical questions about the procurement of the F-35 fighter jets.
Objections and appeals most common obstacles to residential construction projects
This content was published on
Objections and appeals are most frequently responsible for delays in new residential construction projects in Switzerland.
Swiss electricity prices predicted to fall in 2026
This content was published on
Electricity prices in 2026 are likely to be lower than this year, according to a survey. The main reason is the fall in prices on the electricity market.
Mpox virus can also infect the brain, say Swiss scientists
This content was published on
In view of the recent worldwide increase in Mpox cases, these new findings are of great importance, according to the University of Bern.
Switzerland and Ivory Coast sign agreement on cultural assets
This content was published on
Culture Minister Elisabeth Baume-Schneider signed an agreement on cultural assets with Ivorian Culture Minister Françoise Remarck in Côte d'Ivoire on Monday. It is the first of its kind to be concluded with a country from the region.
This content was published on
A snake almost one-and-a-half metres long was discovered on Saturday in a garden in Veltheim, northern Switzerland. It was a red, black and white kingsnake.
This content was published on
The Swiss Broadcasting Corporation (SBC), Swissinfo's parent company, must restructure due to financial pressures and to stay competitive in the fast-moving media environment.
This content was published on
There has been a sharp decline in the consumption of single-use disposable plastic bags and reusable plastic bags in the Swiss retail sector.
This content was published on
A biometric Swiss identity card (ID) is expected to be available in Switzerland by the end of 2026. The Federal Office of Police and its federal and cantonal partners are working on a new ID card that features a chip.
Health experts recommend booster jab against Covid
This content was published on
The Swiss health authorities have called on people over the age of 80 to update their vaccination against the Covid-19 virus.
Switzerland gives green light to Moderna’s Covid vaccine for 6-11 year olds
This content was published on
The Swiss medical regulator Swissmedic has approved Moderna’s Spikevax Covid-19 vaccine for use by children aged 6 to 11 years.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.